by Kristin Rowan | May 9, 2025 | M&A
by Kristin Rowan, Editor UnitedHealth, Amedisys to Divest Home Health & Hospice...Again History UnitedHealth, Amedisys to divest home health and hospice properties to satisfy DOJ. Almost two years ago, the health services division of UnitedHealth Group, Optum,...
by Kristin Rowan | May 1, 2025 | Advocacy, CMS, Editorial, Medicaid, Medicare, Medicare Advantage
by Kristin Rowan, Editor Medicare Advantage It’s no secret within the care at home community that Medicare Advantage is not without its problems. Coverage and care are good when the beneficiary is relatively healthy. When it’s really needed, MA plans deny...
by Kristin Rowan | Mar 7, 2025 | Clinical, CMS, Medicare Advantage, Regulatory
by Kristin Rowan, Editor Easier Access to Home Health Prior authorization requirements can be cumbersome, delaying or even preventing care in some cases. Patients who need prior authorization to get he care they need also generally have form after form to fill out or...
by Kristin Rowan | Jan 9, 2025 | Breaking News, Regulatory
by Kristin Rowan, Editor Just as we were setting the article on UnitedHealth Group and Amedisys for publication, we received the following breaking news story: VitalCaring Divestment Agreement Cancelled VitalCaring entered into the agreement on June 28, 2024, just...
by Kristin Rowan | Jan 9, 2025 | M&A, Regulatory
by Kristin Rowan, Editor UHG and Amedisys Waive Termination The UnitedHealth Group and Amedisys merger has been an ongoing story since the initial merger agreement was signed in June of 2023. The proposed merger came under scrutiny by the Federal Trade Commission...
by Kristin Rowan | Dec 19, 2024 | Advocacy, Regulatory
by Kristin Rowan, Editor Bi-Partisan Bill Introduced The final session of this Congress may not be as “lame” as anticipated. On December 11, 2024, Senators Elizabeth Warren (D-Mass.) and Josh Hawley (R-Mo.), with the support of Representatives Diana...
by Kristin Rowan | Dec 12, 2024 | Breaking News, Medicare Advantage, Regulatory
by Kristin Rowan, Editor Last Week As most of the U.S. now knows, last week, UnitedHealthcare CEO Brian Thompson was shot and killed outside a hotel in Manhattan just hours before the UnitedHealth Group Investor Event. The Rowan Report provided the breaking news story...
by Kristin Rowan | Dec 12, 2024 | Advocacy, Editorial, Medicare Advantage, Regulatory
by Kristin Rowan, Editor Will Thompson's death change healthcare? It's all Relative On the same day that Brian Thompson died, Blue Cross Blue Shield announced a reversal of an earlier planned policy change. In November, the insurance giant announced it would change...
by Kristin Rowan | Dec 4, 2024 | Admin, Breaking News
by Kristin Rowan, Editor United Health CEO in NY for Investor Event On November 26, UnitedHealth Group announced it would host its annual Investor Conference for analysts and institutional investors in New York City on Wednesday, December 4, 2024. The purpose of...
by Kristin Rowan | Nov 15, 2024 | CMS, M&A, Medicare Advantage, Regulatory
by Kristin Rowan, Editor Justice Department Sues In September of 2023, UnitedHealth Group made a bid to purchase Amedysis. That acquisition has been under scrutiny since last year. When the bid was announced, the Department of Justice began an inquiry, asking for...
